Oncology Central

Targeting breast cancer stem cells as a therapeutic strategy


Richard Clarkson is senior lecturer of cancer research in the School of Biosciences (Cardiff University, Cardiff, UK) and is an inaugural member of the European Cancer Stem Cell Research Institute (Cardiff, UK), a purpose-built research facility looking at the causes of and new therapies for cancer with a specific emphasis on cancer stem cells. He received his PhD from the Faculty of Medicine, University of Manchester (Manchester, UK) and carried out research at the University of Queensland (Queensland, Australia) and the University of Edinburgh (Edinburgh, UK), before taking up consecutive fellowships at Cambridge University (Cambridge, UK). In 2005, he moved to Cardiff (UK) to take up a lectureship in translational cancer research. His expertise is in cell and molecular biology – particularly the genetic regulation of cell fate and tissue (cellular) architecture in mammalian tissues.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.